Fundraising Fox
/Companies
Sign in

US Biologic

Memphis, US · Tennessee corporation · 1 known investors

Find your way into US Biologic

Sign up to see every warm intro you have to US Biologic

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the US Biologic team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

US BIOLOGIC develops orally delivered vaccines for disease prevention, applying partner technologies to its oral-delivery platform for wildlife, companion animals, food animals, and humans. The company handles funding, regulatory support, manufacturing, and distribution to commercialize these preventative products.

AgTechBiotechHealthtech

Founders & leadership

MKMason Kauffman
Mason KauffmanCEO & Board Chairman2012–2026Mason Kauffman holds a BS from the University of Michigan and an MBA from the University of Memphis. He spent 16 years at FedEx before founding and exiting Express Logistics and Accuship, both recognized by Inc. Magazine as among the fastest-growing companies; he now serves as Executive Officer and Director at US Biologic, an oral vaccine delivery platform company.
MS
Michael ShmerlingNamed on SEC filing
TM
Thomas MonathNamed on SEC filing
TT
Tommy ThompsonNamed on SEC filing
DW
David WilliamsNamed on SEC filing
CPChris Przybyszewski
Chris PrzybyszewskiPresident & Board Director, Co-Founder

Board

MG
Maria Gomes-SoleckiSenior Advisor / Inventor of US Biologic's first oral vaccination technology

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2017

▶$1MraisedOct 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ShmerlingDirector
  • Thomas MonathDirector
  • Mason KauffmanExecutive Officer, Director
  • Tommy ThompsonDirector
  • David WilliamsDirector
  • Chris PrzybyszewskiExecutive Officer, Director
Offering amount
$2M
Amount sold
$1M
First sale
Sep 2017
Incorporated
Corporation, Tennessee
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
OsmosisOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Companies working in the same space as US Biologic.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of Agriculture (USDA)Phase II2016$598.5K
Department of Agriculture (USDA)Phase I2015$98.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does US Biologic do?
US BIOLOGIC develops orally delivered vaccines for disease prevention, applying partner technologies to its oral-delivery platform for wildlife, companion animals, food animals, and humans. The company handles funding, regulatory support, manufacturing, and distribution to commercialize these preventative products.
Who are US Biologic's investors?
US Biologic's investors include Launch Tennessee.
How much funding has US Biologic raised?
US Biologic has disclosed $1M raised across 1 round.
Where is US Biologic headquartered?
US Biologic is headquartered in Memphis, US.